[ad_1]
The UK Independent Medicines Regulatory Agency (MHRA) authorized the use of vaccine manufactured by Pfizer-BioNTech against coronavirus. The green light comes “after months of rigorous clinical testing and in-depth data analysis by MHRA experts, who concluded that the vaccine met their rigorous standards. safety, quality and efficacy standards“The British Minister of Health Matt hancock He said that the NHS, the national health system, is ready and the vaccination campaign will begin next week. The United Kingdom thus becomes the first country in the world to approve the Pfizer-BioNTech vaccine for widespread use. Albert Bourla, CEO of the pharmaceutical company, described the regulator’s decision as “a historic moment” in the battle against the pandemic.
Pfizer-BioNTech vaccine: first 10 million doses in the next few days
Even the BBC confirms that the first administrations of the vaccine will take place in the next few days and that the first ten million doses will be injected into the most vulnerable and exposed subjects. Another 40 million doses, enough to vaccinate 20 million people with two injections each, will arrive in the first months of 2021. Never in history has a vaccine taken so little time – only ten months – to pass from the first studies green light to mass administration. Although vaccinations may start soon in the UK, people have been urged to continue to strictly adhere to the rules, limiting contact, wearing masks and maintaining physical distance.
Who will get the first doses of the vaccine in the UK
British government consultants have drawn up a still provisional list of subjects who will be vaccinated with priority against the coronavirus. The first will be nursing home residents and staff, followed by those over 80 and other health and social workers who should get their first doses at Christmas. Mass immunization of all younger people can take place gradually over the next few months as supplies become available. The Pfizer-BioNTech vaccine will be given in two injections 21 days apart.
Side Effects of the Pfizer-BioNTech Vaccine
Clinical studies conducted with the Pfizer-BioNTech vaccine so far have not shown side effects: Mild to moderate adverse reactions similar to those that may arise after administration of the flu vaccine, such as injection site pain, fever, and headache have been discussed. However, as highlighted by several experts and participants in clinical trials in an editorial published in the authoritative scientific journal Science, the intensity of these symptoms in some cases would have been significantly greater than that of common vaccines. It is emphasized that these events are not dangerous at all, but that this experience can be quite “intense.”
[ad_2]
